SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Tejnaksh Healthcare informs about disclosure

08 Nov 2022 Evaluate
Tejnaksh Healthcare has informed that the Managing Director of the company was invited to speak at the Joint Andrology Workshop and World Congress JAWS 2022 at New Delhi, India held from 5th to 7th August 2022. He spoke on the disposable' uroflowmetry which is a disposable urine flow measuring kit. This is an innovation of Tejnaksh Healthcare. The conference was the Biggest Andrology and Sexual Health event of 2022 meant for sexual medicine practitioners and medical industry. The kit allows one to check urine flow test at home and know if one needs to visit a urology doctor. It is Sterilized, Hygienic, Safe and allows the test to be conducted in a natural environment at home. It is a boon for the homebound, chair- ridden & bed-ridden patients.

The above information is a part of company’s filings submitted to BSE.

Tejnaksh Healthcare Share Price

15.06 0.04 (0.27%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×